Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 4
Submit an article Journal homepage
261
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

A novel method to investigate drug resistance in the chronic lymphocytic leukemia (CLL) microenvironment: Analysis of CLL Cellular Environment and Response (ACCER)

Tricia Choquettea CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, Manitoba, Canada;b Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, CanadaView further author information
,
Elizabeth S. Hensona CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, Manitoba, Canada;b Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, CanadaView further author information
,
Xiaoyan Yangc Department of Oncology, University of Alberta, Edmonton, Alberta, CanadaView further author information
,
James B. Johnstona CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, Manitoba, Canada;d Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaView further author information
&
Spencer B. Gibsona CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, Manitoba, Canada;b Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada;c Department of Oncology, University of Alberta, Edmonton, Alberta, CanadaCorrespondence[email protected]
View further author information
Pages 822-834 | Received 10 Mar 2022, Accepted 29 Dec 2022, Published online: 19 Feb 2023

References

  • Byrd J. Chronic lymphocytic leukemia. Toronto, ON Canada: Leukemia & Lymphoma Society of Canada; 2019.
  • Cancer Stat Facts: Leukemia – Chronic Lymphocytic Leukemia (CLL). National Cancer Institute, surveillance, epidemiology and end results program; Bethesda MD: National Cancer Institute 2019.
  • Strati P, Ferrajoli A, Lerner S, et al. Fludarabine, cyclophosphamide, and rituximab (FCR) plus GM-CSF as frontline treatment for patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2014;55(4):828–833.
  • Trimarco V, Ave E, Facco M, et al. Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival. Oncotarget. 2015;6(39):42130–42149.
  • Quiroga M, Balakrishnan L, Kurtova A, et al. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood. 2009;114(5):1029–1037.
  • Deglesne P-A, Chevallier N, Letestu R, et al. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression. Cancer Res. 2006;66(14):7158–7166.
  • Burger J, Ghia P, Rosenwald A, et al. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood. 2009;114(16):3367–3375.
  • Paduano F, Gaudio E, Mensah A, et al. T-cell leukemia/lymphoma 1 (TCL1): an oncogene regulating multiple signaling pathways. Front Oncol. 2018;8:317.
  • Decker S, Zwick A, Saleem S, et al. Optomized xenograft protocol for chronic lymphocytic leukemia results in high engraftment efficiency for all CLL subgroups. Int J Mol Sci. 2019;20:6277.
  • Zhang W, Pelicano H, Zeng J, et al. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms. Mol Med Rep. 2015;12(5):7374–7388.
  • Zhang W, Trachootham D, Liu J, et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol. 2012;14(3):276–286.
  • Ding L, Zhang W, Yang L, et al. Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia. Onco Targets Ther. 2018;11:5151–5170.
  • Kurtova A, Balakrishnan K, Chen R, et al. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood. 2009;114(20):4441–4450.
  • Rodenhizer D, Dean T, Xu B, et al. Three-dimensional engineered hetergeneous tumor model for assessing cellular environment and response. Nat Protoc. 2018;13(9):1917–1957.
  • Rodenhizer D, Cojocari D, Wouters B, et al. Development of TRACER: tissue roll for analysis of cellular environment and response. IOP Sci Biofabricat. 2016;8(4):045008.
  • Rodenhizer D, Gaude E, Cojocari D, et al. A three-dimensional engineered tumor for spatial snapshot analysis of cell metabolism and phenotype in hypoxic gradients. Nat Mater. 2016;15(2):227–234.
  • Young M, Rodenhizer D, Dean T, et al. A TRACER 3D co-culture tumor model for head and neck cancer. Biomaterials. 2018;164:54–69.
  • Derda R, Tang S, Laromaine A, et al. Multizone paper platforms for 3D cell cultures. PLoS One. 2011;6(5):e18940.
  • Sbara F., Pinos R., Barbaglio F., et al 3D bioprinting allows establishment of long-term 3D culture model for chronic lymphocytic leukemia cells. Front. Immunol. 2022;12:639572
  • Derda R, Laromaine A, Mammoto A, et al. Paper-supported 3D cell culture for tissue-based bioassays. Proc Natl Acad Sci U S A. 2009;106(44):18457–18462.
  • Barbaglio F., Belloini D., Scarfo L. et al Three deminional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific responses to mobilizing agents. Haematologica 2021;106:2334–2344.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.